ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Short-Courses on Pharmacoeconomics

Flagship Course on Health Sector Reform and Sustainable Financing, World Bank, Economic Development Institute, (collaboration with Harvard University, School of Public Health) Washington/USA, 1998 and 1997

Healthcare Management Certificate Program, Turkish Medical Association, Ankara/Turkey, 1997,

MSc On Health Care Management, Hacettepe University School of Medicine, School of Health Administration, Ankara/Turkey, 1997

Tourism Medicine Certificate Program, Turkish Medical Association, Ankara/Turkey, 1994

Undergraduate - Eskisehir University, School of Medicine, Eskisehir/Turkey, 1992

High School - Ankara Anatolian High School, Ankara/Turkey, 1984

Middle School - Sheffield Lydgate Middle School, Sheffield/England, 1979

Primary School - Çankaya Primary School, Ankara/Turkey, 1975

Experienced in pharmaceutical sector key policy issues such as; Market Access, reimbursement, pricing, health economics/pharmacoecomics, health policy and and public&government affairs. Conducted various analysis on health and pharmaceutical expenditures; supervised health economics and pharmacoeconomics studies; initiated health policy studies and surveys specifically on National Health Accounts, Health Technology Assessment, Disease Management, Family Physician System, Health Economic Model Adaptation Health Economics/Pharmacoeconomics trainings with multilateral stakeholders including World Bank, WHO, OECD, Ministry of Health, Ministry of Finance, Ministry of Labor and Social Security, Treasury, State Planning Organisation and Social Security Institution and worked closely with high-level policy/decision makers on unique partnership projects. Especially experience in specific therapeutic areas such as oncology, MS, diabetes, ophthalmology, women’s health and biotechnology products. International experience as taken role in Market Access Europe Team and Global Brand Teams. Experienced in health sector development, organization and management development, strategic planning, implementation, development of privatization strategy regarding Health Systems, Healthcare Management, Health Policy Healthcare Finance, Health Economics/Pharmacoeconomics and Health Insurance and Turn-Key Hospital Projects. Experienced in international World Bank/UN and local project management and sectoral restructuring projects. Preparation of Terms of Reference (ToR) and bidding documents, contracting out goods, works and services, contract management. Preparation of project proposals in accordance with the World Bank/UN procurement and financial procedures.

: Market Access Coordinator, AİFD (Association of Research-Based Pharmaceutical Companies)

Responsible from pricing and reimbursement issues including stakeholder management primarily coordinating Access Strategic Management Committee together with Pricing and Reimbursement Task Forces.

: Market Access Director, BayerTurkey

Responsible from Health Economics, Health Policy, Market Access, Reimbursement and Pricing functions of Bayer Healthcare Group (both Pharma, Consumer Care, Radiology&Intervention and Dermatology). Permanent member of Access Core Team (ACT Team) of Bayer HQ representing the EMEA Region for developing overall Market Access Strategies and country based execution, Member of Bayer Global Health Policy and Public Affairs and Global Brand Teams. Representation the company in various platforms such as; TÜSİAD, YASED, TOBB, SÜRDER, AIFD. Member of Senior Executive Turkey Task Force.

Major Achievements (significant contribution for business enabling to exceed the target budget):

• Reaorganisation of Market Access team, recruitment of team members and development of job descriptions
• 67 Price Increase Approvals
• 16 Mandatory Institutional Discount Exemptions
• 2 de-listing
• 17 reimbursement approvals
• 10 Health Economic Model Adaptation
• 9 Expert Panels
• 33 International Scientific Publications
• Bayer Regional Advocacy & Health Economics Training

: Market Access Manager, Sanofi-Aventis Turkey

Responsible from Health Economics, Health Policy, Market Access, Reimbursement and Pricing functions of Sanofi-aventis Group (both Sanofi-aventis and Zentiva portfolio).

Main area of responsibilities are; obtain optimum reimbursement and market access conditions for new products (including new indications and line extensions) and lead all the related processes; maintain and improve optimum reimbursement and market access conditions for current in-line products; help provide the evidence and knowledge to support to secure optimal reimbursement of our products; lead all the related processes pertaining to pricing; monitor healthcare environment and improve policy decision environment for a favorable health policy; work for a positive healthcare environment; stakeholder management on health policy, health economics, market access, reimbursement and pricing issues.

Taken role in Market Access Europe Team as well as Global Brand Teams developing Market Access Strategy Plans and enrolling to other countries. In addition leading strategic initiatives with other departments especially marketing and sales. Representation the company in various platforms such as; TÜSİAD, YASED, AIFD, IEIS.

Major Achievements in 2010:

• Reaorganisation of Market Access team, recruitment of team members and development of job descriptions
• 19 reimbursement dossier submissions and approvals
• Reverse of prescription restriction of major product within Health Implementation Guideline (HIG) through partnership with specialty organizations, KOLS and AIFD
• Settlement of a dispute of product with MoH and SSI
• Finalisation of Zentiva Combination Project after Merge&Acquisition
• Completion of Sanofi-aventis Stakeholder Analysis project
• Health Economic Studies and Publications (Osteporosis Cost Study, Thromboatherosis Cost Study, Oncology Data Mining Project, Adaptation of Lantus Health Economic Model, Adaptation of Multaq Health Economic Model)
• Translation and distribution of two Health Economic Classical Textbooks (Lieven Annemans and Gisela Kobelt)
• Health Economics Training and Seminar for 150 top public decision-makers and 50 associates

: Health Policy and Health Economics Manager, Sanofi-Aventis Turkey

Established the Health Policy and Health Economics Department.

Monitoring, assessing changes in healthcare environment with special respect to impact on core business and regularly reporting to top management in Turkey and global headquarters.

Leading strategic initiatives with other departments especially marketing, sales and market access. Collaborating with stakeholders to develop and conduct initiatives/studies to maintain a favorable healthcare environment focusing to shape the health policy process.

Conducting Health Policy and Health Economics projects including pharmacoeconomic analysis and providing scientific evidence and knowledge to secure optimal reimbursement of products.

Adapting global health economic models to Turkey for reimbursement, access and marketing issues. Improving policy environment for a favorable reimbursement policy.

Organizing Health economics and pharmacoeconomics training for both industry and public institutions. Representation the company in various platforms such as; TÜSİAD, YASED, AIFD, IEIS.

: Health Policy Associate Coordinator, Pfizer Turkey

Took role in creating greater influence on external environment of the company specifically on the government and on key policy issues such as IPR, reimbursement and pricing.

Conducted periodical analysis on health and pharmaceutical expenditures; potential saving areas in State Pharma Budget (OTC&Free Goods/Industry Discounts); supervised health economics and pharmacoeconomics studies; initiated health policy studies and surveys specifically on HTA and Disease Management.

Assisted in representing the corporation in matters involving governments or ministries by providing policy direction and coordinating efforts with HQ. Represented Pfizer before various third parties under supervision of his direct boss.

Representation the company in various platforms such as; TÜSİAD, AIFD.

: Projects Coordinator, Environment, Education, Health and Social Solidarity Foundation (ÇESAV)

Took role in designation, implementation, monitoring and coordination of environment, education and health and sectoral restructuring projects on local and international basis.

Took role in running a 50-bedded hospital in Salihli/Manisa and health center in Karşıyaka/İzmir. Took role in Consulting Services for Health Expenditure Anaysis co-financed by World Bank and Rebuplic of Azerbaijan (Second Institution Building Technical Assistance – IBTA II) in Baku-Azerbaijan.

Took role in Consulting Services for World Bank – Turkey Poverty Report, Qualitative Support Survey.

: Performance Measurement and Evaluation Study for the State Hospitals, Ministry of Health

Took role in the designation and Implementation of Performance Measurement and Evaluation Study for the State Hospitals in terms of service provision and cost- analysis.

: Regulation Compliance Studies, The Ministry of Health, Department of European Union

Took role in the regulation compliance studies to EU norms in the context of National European Union Strategy Document concerning health-related fields.

: Health System Master Plan Study for Military, Tepe Teknolojik Sistemler A.S. - Bilsim Bilisim - İletisim Sistemleri ve Yazılım A.S. Strategic Alliance

Took role in preparation of Health Master Plan Study for Military within the context of health care services provision, funding and utilisation of services regarding objectives, scope of work and implementation for the period 2001-2005.

: Insurance Strategy Development and Planning Health Care Services, Ihlas Hayat Sigorta A.S. (Ihlas Life) - Ihlas Holding

Retained by İhlas Life Insurance Inc. to develop a new approach and strategy for their Health Care Insurance System that will reduce health costs, improve health status, and increase satisfaction of membership - a managed health care strategy to achieve a market lead in Turkey.

Conducted the financial analyses of health insurance plans of top private health insurance firms in Turkey; contributed to the SWOT analyses of private health insurance companies, health service providers and insurance plans (products) and financial forecasts of the sector.

: Health Management Specialist Bilsim Information Tech. Inc.; Development of STRAMED-Strategic Analysis & Simulation Software

Prepared the Financial and Accounting Modules of STRAMED - a management decision support & simulation software for health institutions. Prepared the simulation models of the basic financial instructions and financial evaluation Modules.

: Military Service, Gülhane Military School of Medicine

Took role in development and implementation of Hospital Quality System.

: Deputy Coordinator, The Ministry of Health, Health Project General Coordination Unit

Assisted in the direction of the Health Reform Program activities under the First, Second and Primary Health Project, which is supported by the World Bank in terms of finance and technical knowledge in the field of supervision, preparation, design and implementation. Carried out bidding procedures for the recruitment of technical assistance; participated in the evaluation process and provided technical assistance in accordance with World Bank rules and regulations. Assisted in the high priority projects of Ministry of Health (Turn-Key Hospital Structuring of 5 Hospitals) in the field of supervision, preparation, design and implementation. Took role in project preparation, coordination and implementation of Primary Health Care Services Project, co-financed by the World Bank in two pilot provinces. The Primary Health Care Services Project's major aims was to; develop a pilot Primary Health Care system based on the "Family Physician" (training of Family Physicians, General Practitioners and in-service training) and an effective "Referral System" supported by improved infrastructure, (upgrading, renovations, procurement of medical equipment, furniture and PHCS Information Systems). In addition to these; to evaluate the developed system for nationwide replication, to develop capacity for health economic analysis within the Ministry of Health.

Also assisted in the direction of the studies on Health Financing Policies, General Health Insurance Scheme, Self-governing State Hospitals, Reorganization and Decentralization of the MOH organization, strategy development and implementation of a comprehensive Health Information Systems Program. Tasks include the preparation of the legislation on Health Financing Institution (establishment of General Health Insurance System in Turkey); Health Enterprises Law (self governing state hospitals), and a new Ministry of Health Organization Law; overseeing the preparation of reform legislation on Primary Care (Family Physicians System).

Tasks also include representing the Ministry of Health in the Social Security Reform Committee, contributing to the development of a Social Insurance Policy framework in parallel to the Health Reform policies. Participated in the committee established to conduct the study named "Workload Indicators for Staffing Needs" which is used to determine the optimum staffing need of health service providers.

Took role in the preparation and analysis stages of the "Health Economics Analysis" study that aimed to help in the assessment of the health sector’s financial need and also in establishing the data that will be the basis for the efficient use of resources.

Carried out researches on public and private health insurance schemes, took role in the preparation stage of "National Health Accounts Study" which meets OECD Health Accounts System standards and in addition, it provides a detailed source-in-use matrix in regards to health expenditures and allows monitoring fund flows. Also contributed in the preparation of "National Burden of Disease and Cost-Effectiveness Study" of which objective were to determine losses from premature mortality in addition to loss of healthy life arising from disability regarding health interventions. Initiated preparation studies collaboration with World Bank-Economic Development Institute for the design and implementation of Regional Flagship Course on Health Sector Reform and Sustainable Financing to be held in Turkey comprising participants from other countries within the region.

Assisting the PCU and Ministry of Health on the development of financial systems to support decentralized state hospitals as part of the health reform package; developing a general ledger and basic financial accounting systems for hospitals, a cost accounting system, a system for preparing, monitoring and controlling budgets, appropriate financial reporting to the management executive for monitoring financial performance against targets, a business information system to support business planning and the formulation of strategic financial direction. Participated in the studies of developing laws and regulations regarding the financial management systems of state hospitals to be converted into health enterprises. Assisted in the development of Uniform Accounting System Manual for State Hospitals. Tasks include; assistance of Ankara Numune Hospital Feasibility Study, coordination of PR Campaign for the Health reforms.

Assisted in the direction of the Health Reform Program activities under the First and Second Health Projects, and provided assistance for the preparation of further Institutional Development Programs for the MOH. Also assisted in the direction of the studies on Health Financing Policies, General Health Insurance Scheme, Self-governing State Hospitals, Reorganization and Decentralization of the MOH organization, strategy development and implementation of a comprehensive Health Information Systems Program. Tasks include the preparation of the legislation on Health Financing Institution (establishment of General Health Insurance System in Turkey); Health Enterprises Law (self governing state hospitals), and a new Ministry of Health Organization Law; overseeing the preparation of reform legislation on Primary Care (Family Physicians System).

: Team Leader of Hospital Reform Division, The Ministry of Health, Health Project General Coordination Unit

Participated in the study of restructuring hospital management systems in Turkey and development and implementation of pilot Hospital Management Restructuring Programs.

Provided technical assistance for the hospital decentralization program of Ministry of Health as a part of health reform program, specifically, preparation of draft laws and regulations, coordinate planning and implementation of hospital program. Coordinated and provided technical assistance for the Hospital Management Information Systems program to be carried out by the Hospital Information Systems team.

Prepared service delivery contracts between the hospitals and health enterprises with provincial health directorates convenient to the Turkish Law. Developed a Remuneration Scale and Performance Appraisal System that will be used as a base for service contracts of the employees of Health Enterprises. Participated in Public Information and Communication Study for the promotion of Health Reforms. Participated in the development and implementation of Pilot Implementation of Uniform Accounting System and Development of Computerized Accounting System. Participated in development of an Hospital Quality System.

Participated in development of an Accreditation System for Hospitals. Participated in development of Minimum Standards of Biomedical Instrumentation, Workforce and Physical Area for the Health Enterprises. Prepared Patients' Rights Study and relevant draft regulations.

• ISPOR 18th Annual International Meeting May 18-22, 2013 Sheraton New Orleans, New Orleans, LA, USA
• ISPOR 15th Annual European Congress 2012 – 3-7 November 2012 – Berlin, Germany
• ISPOR 17th Annual International Meeting June 2-6, 2012 Washington, DC, USA
• ISPOR 13th Annual European Congress 2010 – 6-9 November 2010 – Prague, Czech Republic
• Risk-Sharing & Value Based Pricing & Reimbursement Models 2010 – September 13-17 – Washington – USA
• 16th Annual International Meeting 2010 – May 21-25, Atlanta – USA
• ISPOR 12th European Congress 2009 – 24-27 October 2009 – France
• Programme Observatory Venice Summer School 2009 - Innovation and HTA – Italy
• 21st Annual DIA (Drug Information Association) EuroMeeting – Germany
• ISPOR 11th European Congress 2008 – November 8-11 2008, Athena – Greece
• Health Economics and Global Renaissance – 23-26 July 2008, Roma – Italy
• 13th ISPOR International Meeting 2007 – May 3-7 2008, Toronto – Canada
• 10th ISPOR European Congress 2007 – October 20-23 2007, Dublin – Ireland
• 12th ISPOR International Meeting 2007 – May 19-23 2007, Arlington VA – USA
• Pharmaceutical Pricing Summit – April 25-26 2007, London – UK
• 9th ISPOR European Congress 2006 – October 28-31 2006, Copenhagen - Denmark
• Rational Pharmacotherapy Training of Trainees, Gazi University School of Medicine, June 19-23 June 2006, Ankara, Turkey
• Pharmaceutical Policy, Drug Reimbursement and Pricing, Vienna School of Clinical Research, November 11-12 2005, Ankara, Turkey
• 1st International Pharmacoeconomics Symposium, May 23-24 2005, Ankara – Turkey
• International Symposium on Toward an Equitable, Efficient, and High Quality National Health Insurance (10th Anniversary of Taiwan’s National Health Insurance) March 18-19, 2005 Taipei - Taiwan
• 1st Joint ECA-MENA PCU Conference, September 27-30, 2004, Antalya -Turkey
• Second Meeting of the Expert Network on Health Care Reform Strategies in Southern Europe–SOUTHNET, December 17-19 1998, Greece-Thessaloniki-WHO,
• Fourth Annual Project Coordination Units' (PCU) Meeting, June 3-5 1998, Estonia Tallin,
• Flagship Course on Health Sector Reform and Sustainable Financing - World Bank - Economic Development Insitute, October 21 - November 20 1998, USA-Washington DC.,
• OECD ELSA Committee Meeting March 16-18 March 1998, France-Paris-OECD,
• Flagship Course on Health Sector Reform and Sustainable Financing Donor Advisory Board Meeting - World Bank - Economic Development Insitute, January 28-29 1998, Norway-Oslo,
• Flagship Course on Health Sector Reform and Sustainable Financing - World Bank - Economic Development Insitute, October 19 - November 24 1997, USA-Washington DC.,
• Third Annual Project Coordination Units' (PCU) Meeting, September 23 –27 1997, Russia-Moscow,
• OECD Social Policy Ministers' Prepatory Meeting, February 27-28 1997, France-Paris-OECD (OECD ELSA Committee),
• Draft Agenda of the 92nd Session, Synthesis Report on Policy Priorities, Analysis of Caring World, France-Paris- OECD (OECD ELSA Committee),
• Meeting of the Pharmaceuticals and Health Sector in Former Soviet Union, Middle Asia and Caucasian Countries, June 9-10 1996, Istanbul,

• Bayer Market Access Training – Berlin/Germany – May 2012
• Advance Training in Health Economics and Market Access– Sanofi-Aventis, Berlin/Germany – Sanofi-Aventis Turkey – 2008
• Evaluating Evidence in HTA Reports, How do we read cost-effectiveness analysis, Ankara/Turkey – Sanofi-Aventis Turkey – 2008
• Evidence Medicine – PVD HERA /HOMA Workshop – Sanofi-Aventis, Paris/France – Sanofi-Aventis Turkey – 2008
• Vienna School of Clinical Research, Pharmacoeconomics Forum – Pharmacoeconomics Evaluation & Analysis, Pharmaceutical Policy, Drug Reimbursement and Pricing, Ankara/Turkey – Sanofi-Aventis Turkey – 2008
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Reimbursement System in Europe Training, Greece – Sanofi-Aventis Turkey – 2008
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Pharmacoeconomics for Decision Makers Training, Greece – Sanofi-Aventis Turkey – 2008
• Introduction to Clinical Development (Medical Writing) Training, Istanbul/Turkey – Sanofi-Aventis Turkey – 2008
• Pharmacoeconomics/Reimbursement Dossier Preparation, Istanbul/Turkey – Sanofi-Aventis Turkey – 2008
• Basics in Market Access & Health Economics Training – Sanofi-Aventis, Paris/France – Sanofi-Aventis Turkey – 2008
• LSE Health Certificate Program on Pharmacoeconomics, Hacettepe University, Center for Health Economics and Health Policy & London School of Economics, Ankara/Turkey – Pfizer Turkey – 2008
• Certificate Program on Health Economics of Pharmaceuticals and Other Medical Interventions (HEPaMI), The European School of Health Economics, Nice – Cannes/France – Pfizer Turkey – 2008
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Pharmacoeconomic Modelling, Ireland – Pfizer Turkey – 2007
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Transferability of Cost-Effectiveness Data Between Countries, Ireland – Pfizer Turkey – 2007
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Cost- Effectiveness Analysis Alongside Clinical Trials, USA – Pfizer Turkey – 2007
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Finding and Extracting Cost Data, USA – Pfizer Turkey – 2007
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Healthcare and Reimbursement Systems in Europe, Denmark – Pfizer Turkey – 2006
• ISPOR (International Society for Pharmacoeconomics and Outcomes Research) Certificate Course on Pharmacoeconomics for Decision Makers, Denmark – Pfizer Turkey – 2006

• International Society for Pharmacoeconomics and Outcomes Research (ISPOR) and ISPOR Turkey Chapter
• International Health Economics Association (IHEA); Health Technology Assessment International (HTAi); DIA
• AİFD; SÜRDER
• TÜSİAD; TOBB; YASED

: Chief of Emergency Medical Team – President of Turkey

: Ankara Numune Hospital – Emergency Service